research use only
Cat.No.S2586
|
In vitro |
DMSO
: 29 mg/mL
(201.2 mM)
Ethanol : 29 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 144.13 | Formula | C6H8O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 624-49-7 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | BG-12 | Smiles | COC(=O)C=CC(=O)OC | ||
| In vitro |
Dimethyl fumarate (DMF) causes short-lived oxidative stress, which leads to increased levels and nuclear localization of the transcription factor nuclear factor erythroid 2-related factor 2 and a subsequent increase in glutathione synthesis and recycling in neuronal cells. It inhibits dendritic cell (DC) maturation by reducing inflammatory cytokine production (IL-12 and IL-6) and the expression of MHC class II, CD80, and CD86. This compound impairs nuclear factor κB (NF-κB) signaling via reduced p65 nuclear translocalization and phosphorylation. It inhibits maturation of DCs and subsequently Th1 and Th17 cell differentiation by suppression of both NF-κB and ERK1/2-MSK1 signaling. DMF inhibits TNF-alpha-induced nuclear entry of NF-kappaB in rat heart endothelial cells (RHEC). As an immune modulator and inducer of the antioxidant response, it suppresses HIV replication and neurotoxin release. It also attenuates CCL2-induced monocyte chemotaxis, suggesting that this compound could decrease recruitment of activated monocytes to the CNS in response to inflammatory mediators. |
|---|---|
| In vivo |
Dimethyl fumarate (DMF) inhibits nuclear entry of NF-kappaB in RHEC and reduces myocardial infarct size after ischemia and reperfusion in rats in vivo. Its oral administration is shown to upregulate mRNA and protein levels of Nrf2 and Nrf2-regulated cytoprotective genes, attenuate 6-OHDA induced striatal oxidative stress and inflammation in C57BL/6 mice. |
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | NRF2 / IRP2 / FBXL5 / FTH1 / FTL |
|
28289076 |
(data from https://clinicaltrials.gov, updated on 2024-05-22)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT06409429 | Not yet recruiting | Pancreatic Cancer |
Tianjin Medical University Cancer Institute and Hospital |
May 1 2024 | Phase 2|Phase 3 |
| NCT06349889 | Not yet recruiting | Nasopharyngeal Carcinoma|Nasopharyngeal Cancer |
Sun Yat-sen University|Nanfang Hospital Southern Medical University|West China Hospital |
May 1 2024 | Phase 2 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.